Alkermes
ALKS
#2383
Rank
NZ$13.81 B
Marketcap
NZ$82.21
Share price
3.05%
Change (1 day)
41.67%
Change (1 year)

Operating Margin for Alkermes (ALKS)

Operating Margin as of November 2026 (TTM): 19.74%

According to Alkermes's latest financial reports and stock price the company's current Operating Margin is 19.74%. At the end of 2022 the company had an Operating Margin of -15.05%.

Operating Margin history for Alkermes from 2001 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
2022-15.05%349.36%
2021-3.35%-63.97%
2020-9.29%-44.78%
2019-16.83%45.04%
2018-11.60%-26.84%
2017-15.86%-44.84%
2016-28.75%-19.36%
2015-35.65%1472.47%
2014-2.27%-136.82%
20136.16%-120.99%
2012-29.33%17.76%
2011-24.91%-0.65%
2010-25.07%-162.55%
200940.08%-44.17%
200871.80%1534.17%
20074.39%-46.42%
20068.20%-110.3%
2005-79.60%-67.99%
2004-248.65%9.95%
2003-226.16%99.42%
2002-113.41%276.67%
2001-30.11%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
34.58% 75.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
22.03% 11.60%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
12.01%-39.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
13.21%-33.08%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
22.64% 14.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
21.11% 6.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-259.55%-1,414.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-84.50%-528.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
7.08%-64.13%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.